JORNAY PM

About collegium-pharmaceutical

Collegium Pharmaceutical is a publicly traded, commercial-stage biopharmaceutical company with a strategic focus on pain management and neuropsychiatry. The company has established itself through a disciplined strategy of portfolio diversification, specializing in abuse-deterrent formulations and the acquisition/commercialization of differentiated medicines. Under new leadership, Collegium is executing on a growth trajectory, aiming to strengthen its position in ADHD and expand its impact through a commitment to science, corporate responsibility, and robust commercial execution.

Therapeutic Areas